In this interview, Konstantinos discusses how improvements in mass spectrometry sensitivity are enabling researchers to ...

This article explores how advances in AI, structural biology, and new drug modalities are transforming “undruggable” proteins ...

Precision bacteriophages reduced gut inflammation by blocking harmful bacterial activity, while boosting the effects of a ...

A streamlined gene editing platform enables tissue-wide CRISPR screening in human organoids, identifying genes that regulate ...

Researchers combined engineered viral vectors with the brain’s glymphatic transport system to deliver genes to glial cells.

Many cancer-associated mutational signatures remain unexplained. Team CAUSE aims to connect DNA damage, mutational patterns, ...

Researchers tested KCL-286 in Alzheimer’s models, finding it reduced DNA damage and inflammation. The drug targets retinoic ...

Using a genome-wide CRISPR screen and AI analysis, researchers uncovered unexpected psoriasis drug targets, including the ...

This listicle examines the technical foundations, readiness levels, and performance trade-offs shaping the future battery ...

An AI approach has been developed that accurately predicts how quickly drug-delivery materials release therapies, potentially ...

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer. The discovery expands our understanding of the ...